🔎 Today’s Daily Sift: Longevity The wellness economy is transforming into something far larger than supplements, fitness apps, and self care culture. Today’s signals show longevity evolving into a new operating system for human performance. The biggest shift is philosophical. Healthcare is moving from treating decline to engineering resilience before decline appears. AI and biotech are accelerating this transition rapidly. Life Biosciences just received FDA clearance to begin human testing of ER100, a partial cellular reprogramming therapy designed to reset biological age markers using Yamanaka factor science. Age reversal is no longer trapped in theory. It is entering regulated human trials. At the same time, Insilico Medicine launched the industry’s first Longevity Board focused entirely on AI driven aging therapeutics. The language around aging is changing fast. Scientists and investors increasingly view aging itself as an editable biological layer. Another emerging frontier...